Biggest News Aggregation in the World
📰 Marcus News

Page 47 - Marcus News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Marcus. Real-time updates on events, politics, business and more.

Brokerages Set Arcus Biosciences, Inc. (NYSE:RCUS) PT at $44.00

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year […]
United States Jennifer Jarrett Securities Exchange Commission Gilead Sciences Inc Arcus Biosciences Company Profile Arcus Biosciences Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Truist Financial Reaffirms Buy Rating for Arcus Biosciences (NYSE:RCUS)

Truist Financial restated their buy rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a report published on Wednesday, Benzinga reports. Truist Financial currently has a $50.00 price target on the stock. Other research analysts also recently issued reports about the stock. Morgan Stanley cut their price objective on shares of Arcus Biosciences […]
United States Jennifer Jarrett Dimensional Fund Advisors Securities Exchange Commission Arcus Biosciences Inc Lazard Asset Management

Bank of America Raises Arcus Biosciences (NYSE:RCUS) Price Target to $23.00

Arcus Biosciences (NYSE:RCUS – Free Report) had its target price upped by Bank of America from $21.00 to $23.00 in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has a neutral rating on the stock. Other research analysts also recently issued reports about the company. BTIG Research reiterated […]
United States Jennifer Jarrett Arcus Biosciences Inc Sectoral Asset Management Inc Panagora Asset Management Inc Arcus Biosciences Company Profile

Arcus Biosciences' (RCUS) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a report released on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $46.00 price target on the stock. Several other equities analysts also recently issued reports on RCUS. Mizuho reiterated a buy rating and issued a $51.00 price objective […]
United States Jennifer Jarrett Cantor Fitzgerald Arcus Biosciences Company Profile Securities Exchange Commission Hermes Inc

Professional Investing for Everyone: Akylbek Apaitov and Andrew Marcus Talk on Kappa: Stock Screener

In a rapidly evolving world of stock investing, innovative platforms are emerging to meet the growing demand from retail investors. One such platform making waves in the United States is Kappa: Stock Screener. Akylbek Apaitov and Andrew Marcus have combined their expertise to change the way ordinary people invest in stocks.
United States Andrew Marcus David Thompson Nassim Taleb Warren Buffett Akylbek Apaitov

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science